Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar
852.1500 0.75 (0.09%)
NSE Sep 16, 2025 15:31 PM
Volume: 312.3K
 

logo
Natco Pharma Ltd.
13 Aug 2020
852.15
0.09%
ICICI Securities Limited
Natco has carved out its own identity via tie-ups to tap limited but niche products pipeline including 20 Para IVs filings (FY20). As per the revised and more feasible game plan, it plans to market products via tie-ups with established players in the generic space. Till FY19, the company had filed 51 ANDAs, which includes some niche FTF opportunities. Overall, the...
Natco Pharma Ltd. has an average target of 1297.50 from 4 brokers.
More from Natco Pharma Ltd.
Recommended